<DOC>
	<DOCNO>NCT00568061</DOCNO>
	<brief_summary>The purpose study ass whether inhaled nitric oxide decrease myocardial infarction ( MI ) size 48-72 hour patient present ST segment elevation MI ( STEMI ) undergo successful percutaneous coronary intervention .</brief_summary>
	<brief_title>Nitric Oxide Myocardial Infarction Size</brief_title>
	<detailed_description>The purpose trial ass whether inhaled nitric oxide decrease myocardial infarction ( MI ) size fraction leave ventricular ( LV ) size 48-72 hour patient present ST segment elevation MI undergo successful percutaneous coronary intervention ( PCI ) . The primary endpoint study myocardial infarction size fraction leave ventricular size 48-72 hour measure contrast-enhanced cardiac MRI .</detailed_description>
	<mesh_term>Infarction</mesh_term>
	<mesh_term>Myocardial Infarction</mesh_term>
	<mesh_term>Nitric Oxide</mesh_term>
	<criteria>Acute myocardial infarction electrocardiographic evidence ST elevation No clinical evidence congestive heart failure All patient must undergo successful percutaneous coronary intervention TIMI 0 1 coronary flow result TIMI 2 3 flow Greater 18 year age Signed IRB approve informed consent Prior myocardial infarction Requirement urgent cardiac surgery Previous CABG PCI Left bundle branch block Heart block expect require temporary pacemaker great 72 hour Prior use thrombolytic therapy current event Unable tolerate magnetic resonance image unable tolerate gadolinium contrast medium , include patient calculated creatinine clearance le 60ml/min/1.73m² BSA Active recent hemorrhage require invasive procedure evaluation transfusion within 6 week prior presentation , hemorrhagic stroke within 6 week prior Neutropenia ( WBC &lt; 2000 ( mm ) ³ ) , Anemia ( HCT &lt; 30 % , Thrombocytopenia ( Thrombocytes &lt; 50,000 ( mm ) ³ ) . It necessary confirm blood count prior start study drug absence clinical suspicion . Known suspected aortic dissection . Prior history pulmonary disease require chronic oxygen therapy . Pregnancy , lactating , woman childbearing potential . Medical problem likely preclude completion study . Use investigational drug device within 30 day prior enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>INOT44</keyword>
	<keyword>NOMI</keyword>
</DOC>